Human B cell-triggering mechanisms were investigated using the polyclonal activators Staphylococcus aureus Cowan I (SAC) and pokeweed mitogen (PWM). When 
Introduction
Recent studies of the events leading to B cell activation, proliferation, and differentiation have documented that occupancy of membrane-bound Ig by antigen and/or cognate T cell interactions involving the Ia antigens ofresting B cells results in functional expression of receptors for T cell-derived soluble factors, and that it is these factors that in turn stimulate B cells to proliferate and differentiate into cells secreting Ig (1) (2) (3) (4) (5) . Many studies regarding human B cells have used polyclonal B cell activators. These polyclonal activators include mitogens such as a T cellindependent pure B cell mitogen Staphylococcus aureus Cowan I (SAC)' that directly acts on B cells by cross-linking of the Ig receptors on their surfaces and anti-Ig antibody that interacts with the B cell surface Ig. The results of studies with these polyclonal activators suggest that SAC or a high concentration of anti-Ig antibody directly induces the proliferation of resting human B cells, while a less powerful surface-membrane Ig-mediated signal, such as that delivered by low concentrations of anti-Ig antibody, results in the activation of B cells without subsequent proliferation. However, the induction of proliferation by these activated B cells can occur in the presence of B cell stimulatory factors (BSF) (5) (6) (7) (8) (9) (10) . Moreover, the proliferating B cells that have been activated by SAC, a high concentration of anti-Ig antibody, or low concentrations of anti-Ig antibody plus BSF, can in turn be induced to differentiate into Ig-secreting cells by B cell differentiation factors (BCDF) (5) (6) (7) (8) (9) (10) .
Many ofthe great advances in our understanding of the regulatory mechanisms that control human Ig synthesis have emerged from studies that have used another polyclonal activator, pokeweed mitogen (PWM) (11) (12) (13) (14) (15) . PWM is a T celldependent T cell and B cell mitogen and induces proliferation and differentiation of B cells into Ig-secreting cells under the adequate help of T cells (1 1, 15) . In the present study, we have addressed the question of whether some differences exist in the B cell-triggering mechanisms by SAC and PWM. We have also investigated the role of interactions of Ia-like antigens on (16) (17) (18) .
Preparation ofpartiallypurified Tcell-derivedsolublefactors. Fresh, pooled human peripheral mononuclear cells (2.5 X 106/ml) were stimulated for 48 h with PHA (I sg/ml). The supernatants were collected, purified by several chromatographic steps as described elsewhere (19, 20) , and were designated partially purified T cell-derived soluble factors. The characterization ofthe factors obtained has been described previously (18) (19) (20) . The factors obtained had neither PHA activity nor interferon y activity; they contained BSF activity and BCDF activity as well as interleukin 2 (IL-2) activity.
Overall experimental design. Activated B cells were generated by PWM stimulation in a first culture for 6 h. These cells were washed four times to remove PWM, and further incubated in the presence ofpartially purified T cell-derived soluble factors in a second culture. After incubation of 5 Tcell subsets involved in B cell triggering by PWM. To identify T cell subsets involved in the B cell triggering by PWM, B cell plus monocyte combinations added either with T4' or T8' cells were stimulated with PWM for 6 h in the first culture. Thereafter, B cells were isolated from the first culture and further incubated in the second culture for 5 d in the presence ofT cellderived soluble factors. As shown in Fig. 4 , B cells cultured with T4' cells in the first culture showed vigorous proliferative responses and PFC responses by reacting to T cell-derived soluble factors in the second culture. However, B cells incubated with T8+ cells in the first culture poorly responded in both proliferation and Ig production even ifT cell-derived factors were present in the second culture. These results indicate that B cell triggering by PWM occurs only when T4', but not T8+, cells are in direct interactions with B cells. The results presented here also suggest the possibility ofB cell activation occurring through the interaction of T4 antigens on T cells and Ia-like antigens on B lymphocytes and/or monocytes, since T4 antigens are receptors that recognize class II antigens of the major histocompatibility complexes (MHC) (23) .
Modulation by a series of monoclonal antibodies of B cell triggering by PWM. Anti-Ia, anti-T3, anti-T4, and anti-T8 antibodies were added to the first culture of B cells, T cells, monocytes, and PWM to examine the ability of the individual antibodies to modulate the mechanisms of B cell triggering (Fig.  5) . When the first culture was performed in the presence ofantiIa or anti-T4 antibody, proliferative as well as PFC responses induced in the second culture were remarkably decreased. However, when anti-T3 and anti-T8 antibodies were added to the first culture, both of the responses in the second culture were not inhibited at all. These results strongly support the above hypothesis that T4 antigens on T cells and Ia-like antigens on 296 N. Suzuki w^a nti-Ia-like antibody; a, 25 fsg/ a n t -T 8 -lpml anti-T3 antibody; ., 25 ognition through the interaction of T and B cells (7) . Moreover, when T cell-derived soluble factors including IL-2, BSF, and BCDF coexist, a proliferative state ofthe SAC-stimulated B cells is much enhanced and sustained. In addition, these cells can be further induced to differentiate into Ig-secreting cells (8, 18 (25, 26) . It is also known that T4 antigens play an important role in lymphokine production, helper activity, or cellular interactions by which the proliferation and Ig production can be induced either in autologous mixed lymphocyte reactions or antigen-specific systems (27) (28) (29) . Monoclonal antibodies against T8 antigens selectively interfere with the suppressor activity or cytotoxic activity of T8' cells (25, 26) . More recently, it has been furthor found that T4 and T8 antigens do recognize and respond to MHC antigens, T4 molecules bind to a constant region of a class II MHC gene product, and T8 antigens represent receptors for a constant region of a class I MHC gene product (23) . On the other hand, the antibodies against T3 antigens not only act on T cells and induce their proliferation (30, 31) but also act to suppress functional maturation of T cells after antigenic stimulation (25, 32) as well as to inhibit the development of effector functions of cloned T cells (33) . The antibodies against Ia-like antigens are also known to suppress both cellular immunity and humoral immunity well (4, 34, 35 (Fig. 3) . Moreover, it has in general been known that T cell activation by mitogens, particularly PHA and Con A, requires the recognition of mitogens by the T3-Tin complexes as well as the recognition of Ia-like antigens on macrophages by the T4 antigens (30, 31). The results that anti-T3 antibodies did not block the B cell triggering by PWM (Fig. 5 (37) and that some activated T4+ cells function in the role of suppressor cells (14, 16, 38) . However, it is very unlikely that suppressor function by either T4+ or T8+ cells that might be generated in the first culture might be mediated by anti-Ia antibodies, because anti-Ia antibodies should have first activated either T4+ or T8+ cells and rendered the profound suppressor activity to these cells in the course of 6 h in the first culture. Moreover, these suppressor effector cells should have also inhibited the B cell triggering in the very same course of 6 h in the first culture.
The effect ofa series of monoclonal antibodies in the second culture was also investigated. Once B cells were triggered in the first culture, they proliferated and went on to differentiate into Ig-secreting cells in the second culture, regardless ofthe presence ofanti-Ia, anti-T3, anti-T4, anti-T8, or anti-Tac antibody. IL-2 receptors, Tac antigens, have been found to be expressed on B lymphocytes as well in recent years (39) (40) (41) and it has been documented that IL-2 exerts a direct effect on B cell function (41) . As far as our results are concerned, Ig production was not inhibited even if anti-Tac antibodies were added to the second culture of PWM-activated B cells. Conceivable reasons for this phenomenon would be (a) the possibility that BSF and BCDF as well as IL-2 would be enriched in our preparations of T cellderived soluble factors and that complementary proliferation and differentiation by BSF and BCDF would occur even though the proliferation through interactions of IL-2 and IL-2 receptors is impeded by anti-Tac antibodies and (b) the possibility that B cell subsets activated by PWM would maturate in an IL-2-independent manner. Further study is now underway on this point. On the other hand, the fact that anti-Ia-like antibodies have no inhibitory effect in the second culture indicates that the responsiveness to T cell-derived factors of B cells that once have been activated and become sensitive to the factors could no longer be mediated by Ia-like antigens. Thus, the in vivo use of monoclonal antibodies to regulate immune responses, particularly activation steps of B cells, should require a careful evaluation to determine in which phase(s) of the activation cascade abnormal B cells reside and the selection ofproper monoclonal antibodies, depending on the phase in this cascade. We hope that our results will provide new and potentially important avenues ofapproach to the clinical use of monoclonal antibodies in the future.
